Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

Add Yahoo as a preferred source to see more of our stories on Google. A blood sample for an HIV test is available at the Checkpoint BLN laboratory. The development of the HIV infection-preventing drug ...

The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

"You know, an anti-science attitude together with an anti-vaccine attitude is not very good for the public health of the country or the world," Fauci said.

While medical breakthroughs have made ending HIV transmission a realistic goal, experts warn that stigma and misinformation ...

The BRILLIANT 011 trial is testing two next-generation HIV vaccine components—BG505 GT1.1 and 426c.Mod.Core-C4b—administered alongside the SMNP adjuvant.

Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up, he ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein ...

Hand holding AIDS awareness ribbon with HIV self test and treatment pill. More than 1 million Americans live with human immunodeficiency virus, or HIV, with tens of thousands of new diagnoses each ...

It was as a Ph.D. student that Dionna Williams realized the fundamental flaws in how medical science treats people who have HIV and also use illicit drugs or misuse prescription drugs. People in this ...